Dr. Utkarsh Chris Shukla, MD

Dr. Shukla practices at Surgical Specialty Care in Albuquerque, New Mexico.

Dr. Shukla's NPI, 1437656154, was assigned on April 9, 2018. Dr. Shukla graduated from University of New Mexico School of Medicine in 2018. Dr. Shukla holds New Mexico license MD2023-0189.

Dr. Shukla's primary practice is Surgical Specialty Care, at 4901 Lang Ave Ne, Albuquerque, NM 87109. The practice phone is (505) 842-8171.

Dr. Shukla's primary practice is Surgical Specialty Care in Albuquerque, New Mexico. Dr. Shukla is also affiliated with Lovelace Medical Center. The medical group on file is New Mexico Cancer Center (NMCC). Dmand AI also links Dr. Shukla to 1 more group practice or clinic and 1 therapy and rehab clinic, each named with a free account. Dr. Shukla's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shukla practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Shukla's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Shukla is licensed in New Mexico.

CMS data shows 3,450 Medicare services from Dr. Shukla across 26 procedure codes in 2024, for 270 Medicare patients. Medicare paid $530,465 for them. Every service was in an office.

CMS counts 270 Medicare patients who saw Dr. Shukla in 2024. The largest group is 65 to 74, with 149 patients. 67% of them have cancer, and 63% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shukla's median patient age at 71, with 49% women.

In 2024, Dr. Shukla wrote 269 Medicare Part D claims for 112 patients. 97% of them were for generic drugs. CMS names the drug for 188 of them, across 8 drugs with 11 or more claims each, at $2,058 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Shukla for performance year 2024, reported as part of a group. Dr. Shukla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Shukla, published from 2020 to 2023. 2022 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Radiation Oncology and Radiotherapy Dosage. Dr. Shukla has published most often in Adv Radiat Oncol. Dr. Shukla's most frequent co-authors are David E. Wazer, MD, Kathryn E. Huber, MD, PhD and Avinash Chaurasia, MD.

CMS Open Payments shows 13 general payments to Dr. Shukla from 8 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. RefleXion Medical, Inc. paid the most, $166.

Dr. Shukla graduated from University of New Mexico School of Medicine in 2018.